{"transactions":[{"id":1084629,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:44.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":24734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $70,000. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":54734,"source":{"system":"sec-edgar","filing":"0001140361-25-026410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125026410/form4.xml","form_type":"4"}},{"id":1084628,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:44.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001140361-25-026410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125026410/form4.xml","form_type":"4"}},{"id":1472989,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:22.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":4655,"price":15.04,"value":70011.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 4,655 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000."}],"balance_after":4655,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":4655},"source":{"system":"sec-edgar","filing":"0001140361-24-030724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030724/form4.xml","form_type":"4"}},{"id":1472988,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:22.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":23944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025."}],"balance_after":23944,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23944},"source":{"system":"sec-edgar","filing":"0001140361-24-030724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030724/form4.xml","form_type":"4"}},{"id":1844107,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:51.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":5026,"price":13.93,"value":70012.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 5,026 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000."}],"balance_after":5026,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":5026},"source":{"system":"sec-edgar","filing":"0001140361-23-031527","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123031527/form4.xml","form_type":"4"}},{"id":1844106,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:51.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024."}],"balance_after":25850,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":25850},"source":{"system":"sec-edgar","filing":"0001140361-23-031527","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123031527/form4.xml","form_type":"4"}},{"id":2231309,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:17.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":10283,"price":6.8,"value":69924.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 10,283 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000."}],"balance_after":10283,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":10283},"source":{"system":"sec-edgar","filing":"0001140361-22-023147","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122023147/form4.xml","form_type":"4"}},{"id":2231308,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:17.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":47745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023."}],"balance_after":47745,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":47745},"source":{"system":"sec-edgar","filing":"0001140361-22-023147","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122023147/form4.xml","form_type":"4"}},{"id":2666011,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:19:16.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":2379,"price":29.42,"value":69990.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 2,379 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000."}],"balance_after":2379,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001140361-21-021305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121021305/form4.xml","form_type":"4"}},{"id":2666010,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:19:16.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":12236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022."}],"balance_after":12236,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":12236},"source":{"system":"sec-edgar","filing":"0001140361-21-021305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121021305/form4.xml","form_type":"4"}},{"id":2858717,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Paul Andrew Granadillo 2020 Irrevocable Trust dated 12/28/2020"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":2858716,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":0,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":2858715,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ann Granadillo Lowe 2020 Revocable Trust dated 12/28/2020"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 37,778 of which are currently vested and exercisable, with the remaining 2,222 shares vesting in equal monthly installments  on each of February 28, 2021 and March 29, 2021."}],"balance_after":40000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":2858714,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 37,778 of which are currently vested and exercisable, with the remaining 2,222 shares vesting in equal monthly installments  on each of February 28, 2021 and March 29, 2021."}],"balance_after":0,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":2858713,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Ann Granadillo Lowe 2020 Revocable Trust dated 12/28/2020"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which are currently vested and exercisable."}],"balance_after":30000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":2858712,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T02:57:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which are currently vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-21-005130","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005130/form5.xml","form_type":"5"}},{"id":3105283,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T01:40:03.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-20-014243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120014243/form4.xml","form_type":"4"}},{"id":3682492,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T23:40:35.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020."}],"balance_after":30000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-19-002013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119002013/form4.xml","form_type":"4"}},{"id":3770116,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-09T21:10:45.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":12322,"price":114.5,"value":1410869.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $114.60, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":15335,"source":{"system":"sec-edgar","filing":"0001127602-18-032638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218032638/form4.xml","form_type":"4"}},{"id":3812160,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":10353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":35.5,"exercise_date":"2015-07-23","expiration_date":"2021-07-23","underlying":"Common Stock","underlying_shares":10353},"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812159,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":6573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":45.45,"exercise_date":"2014-07-24","expiration_date":"2020-07-24","underlying":"Common Stock","underlying_shares":6573},"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812158,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":8196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":36.37,"exercise_date":"2013-07-27","expiration_date":"2019-07-27","underlying":"Common Stock","underlying_shares":8196},"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812157,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":631,"price":114.16,"value":72034.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $114 to $114.44, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812156,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":11812,"price":113.16,"value":1336645.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $112.51 to $113.35, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":28288,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812155,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":13183,"price":111.33,"value":1467663.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $110.92 to 111.88, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":40100,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812154,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":3696,"price":110.11,"value":406966.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $109.79 to $110.55, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":53283,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812153,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":1502,"price":108.92,"value":163597.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $108.61 to $109.33, inclusive.  The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":56979,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812152,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":10353,"price":35.5,"value":367531.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":58481,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812151,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":6573,"price":45.45,"value":298742.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":48128,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3812150,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-19T21:00:38.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":8196,"price":36.37,"value":298088.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":41555,"source":{"system":"sec-edgar","filing":"0001127602-18-028076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218028076/form4.xml","form_type":"4"}},{"id":3859542,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-30T22:16:26.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":1696,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":33359,"source":{"system":"sec-edgar","filing":"0001127602-18-024059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218024059/form4.xml","form_type":"4"}},{"id":3976182,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T00:16:45.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years."}],"balance_after":40000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-009124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009124/doc4.xml","form_type":"4"}},{"id":4145361,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":7118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":34.405,"exercise_date":"2012-07-21","expiration_date":"2018-07-21","underlying":"Common Stock","underlying_shares":7118},"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145360,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":40,"price":57.1,"value":2284.0,"ownership":{"direct":true},"balance_after":32381,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145359,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":200,"price":57.09,"value":11418.0,"ownership":{"direct":true},"balance_after":32421,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145358,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":200,"price":57.08,"value":11416.0,"ownership":{"direct":true},"balance_after":32621,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145357,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.0749,"value":5707.49,"ownership":{"direct":true},"balance_after":32821,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145356,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":760,"price":57.07,"value":43373.2,"ownership":{"direct":true},"balance_after":32921,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145355,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":200,"price":57.06,"value":11412.0,"ownership":{"direct":true},"balance_after":33681,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145354,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":4100,"price":57.055,"value":233925.5,"ownership":{"direct":true},"balance_after":33881,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145353,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":9,"price":57.05,"value":513.45,"ownership":{"direct":true},"balance_after":37981,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145352,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.03,"value":5703.0,"ownership":{"direct":true},"balance_after":37990,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145351,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":91,"price":57.02,"value":5188.82,"ownership":{"direct":true},"balance_after":38090,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145350,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.015,"value":5701.5,"ownership":{"direct":true},"balance_after":38181,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145349,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.007,"value":5700.7,"ownership":{"direct":true},"balance_after":38281,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145348,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.005,"value":5700.5,"ownership":{"direct":true},"balance_after":38381,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145347,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":300,"price":57,"value":17100.0,"ownership":{"direct":true},"balance_after":38481,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145346,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":7118,"price":34.405,"value":244894.79,"ownership":{"direct":true},"balance_after":38781,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145345,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.125,"value":5712.5,"ownership":{"direct":true},"balance_after":32281,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145344,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.13,"value":5713.0,"ownership":{"direct":true},"balance_after":32181,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145343,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.14,"value":5714.0,"ownership":{"direct":true},"balance_after":32081,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145342,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.15,"value":5715.0,"ownership":{"direct":true},"balance_after":31981,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145341,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":200,"price":57.17,"value":11434.0,"ownership":{"direct":true},"balance_after":31781,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145340,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":18,"price":57.18,"value":1029.24,"ownership":{"direct":true},"balance_after":31763,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4145339,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T21:14:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":100,"price":57.225,"value":5722.5,"ownership":{"direct":true},"balance_after":31663,"source":{"system":"sec-edgar","filing":"0001127602-17-033796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217033796/form4.xml","form_type":"4"}},{"id":4248980,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-07-31T21:46:17.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":4329,"price":39.27,"value":169999.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit grant which vests 100% on the first anniversary of the grant date.  Grant was made under 2005 Long Term Incentive Compensation Plan."}],"balance_after":31663,"source":{"system":"sec-edgar","filing":"0001127602-17-024397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217024397/form4.xml","form_type":"4"}},{"id":281837,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2005-02-14T23:49:41.000Z","date":"2004-09-23","kind":"gift","acquired":false,"shares":79,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":106316,"source":{"system":"sec-edgar","filing":"0000059478-05-000049","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947805000049/doc5.xml","form_type":"5"}},{"id":281836,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2005-02-14T23:49:41.000Z","date":"2004-09-16","kind":"gift","acquired":false,"shares":16,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":106395,"source":{"system":"sec-edgar","filing":"0000059478-05-000049","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947805000049/doc5.xml","form_type":"5"}},{"id":295097,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Employee stock option (right to buy)","published_at":"2004-02-19T19:47:37.000Z","date":"2004-02-17","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":73.11,"exercise_date":"2007-02-19","expiration_date":"2014-02-14","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000059478-04-000071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000071/doc4.xml","form_type":"4"}},{"id":295159,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2004-02-17T19:46:53.000Z","date":"2003-11-12","kind":"gift","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96559,"source":{"system":"sec-edgar","filing":"0000059478-04-000034","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000034/doc5.xml","form_type":"5"}},{"id":295158,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2004-02-17T19:46:53.000Z","date":"2003-11-05","kind":"gift","acquired":false,"shares":71,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96560,"source":{"system":"sec-edgar","filing":"0000059478-04-000034","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000034/doc5.xml","form_type":"5"}},{"id":295157,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2004-02-17T19:46:53.000Z","date":"2003-07-28","kind":"gift","acquired":false,"shares":75,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96631,"source":{"system":"sec-edgar","filing":"0000059478-04-000034","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000034/doc5.xml","form_type":"5"}},{"id":295156,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13932,"kind":"person","name":"GRANADILLO PEDRO P","position":1,"cik":"0001217544","reported_name":"GRANADILLO PEDRO P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2004-02-17T19:46:53.000Z","date":"2003-06-19","kind":"gift","acquired":false,"shares":123,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96706,"source":{"system":"sec-edgar","filing":"0000059478-04-000034","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000034/doc5.xml","form_type":"5"}}]}